Efficacy of Aclidinium Bromide Administered in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT00868231 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: Aclidinium bromide 400 μg bid
DRUG: Tiotropium 18 μg once-daily
DRUG: Placebo

Sponsor

AstraZeneca